PureTech Health PLC (PRTC)
Industry Biotechnology
This stock can be held in an Investment ISA and an Investment Account
Sell
141.20p
Buy
141.60p
-5.40p (-3.68%)
Prices updated at 01 Oct 2024, 16:47 BST
| Prices minimum 15 mins delay
Prices in GBX
PureTech Health PLC is a cross-disciplinary healthcare company developing products that could improve the lives of patients.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Income statement
Year | 2022 | 2023 |
|---|---|---|
| 2m | 750,000 | |
| - | - | |
| -198m | -146m | |
| -9,464.40 | -19,493.47 | |
| -50m | -66m | |
| -80m | -18m | |
| Sales, General and administrative | 32m | 25m |
| Interest expenses | 4m | 13m |
| Provision for income taxes | -56m | 31m |
| Operating expenses | 200m | 147m |
| Income before taxes | -93m | -36m |
| Net income available to common shareholders | -50m | -66m |
| -0.18 | -0.24 | |
| Net interest income | 2m | 3m |
| Advertising and promotion | - | - |
| Net investment income, net | 14,000 | -94,000 |
| Realised capital gains (losses), net | - | - |
| Total benefits, claims and expenses | - | - |
| Earnings per share (diluted) | -0.18 | -0.24 |
| Free cash flow per share | -0.5331 | -0.4412 |
| Book value/share | 1.7324 | 1.4841 |
| Debt equity ratio | 0.063441 | 0.039326 |
Balance sheet
Year | 2022 | 2023 |
|---|---|---|
| Current assets | 386m | 347m |
| Current liabilities | 97m | 51m |
| Total capital | 552m | 464m |
| Total debt | 47m | 25m |
| Total equity | 542m | 464m |
| Total non current liabilities | - | - |
| Loans | 10m | - |
| Total assets | 703m | 694m |
| Total liabilities | - | - |
| Cash and cash equivalents | 150m | 191m |
| Common stock | 279m | 272m |
Cash flow
Year | 2022 | 2023 |
|---|---|---|
| Cash at beginning of period | 466m | 150m |
| Cash dividends paid | - | - |
| -181m | -106m | |
| Investments (gains) losses | -107m | 69m |
| 150m | 191m | |
| Net income | - | - |
| -179m | -106m | |
| -2m | -245,000 |
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison. 